Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Nicholas

Showing results (101-110 of 165) with videos related to

Pageof 17
Sort By:
Annals of Neurology|February 14, 2025
Mapping Molecular Pathways of Multiple Sclerosis: A Gene Prioritization and Network Analysis of White Matter Pathology TranscriptomicsGianmarco Abbadessa, Ai Nagano, Simon Hametner, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|August 6, 2016
A Comparison of Magnetization Transfer Methods to Assess Brain and Cervical Cord Microstructure in Multiple SclerosisAlfonso Lema, Courtney Bishop, Omar Malik, et al.
Neurology|July 6, 2012
Increased PK11195 PET binding in the cortex of patients with MS correlates with disabilityMarios Politis, Paolo Giannetti, Paul Su, et al.
Brain : a Journal of Neurology|August 16, 2011
Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosisOwain W Howell, Cheryl A Reeves, Richard Nicholas, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 1, 2022
Management approach including pembrolizumab for fingolimod-associated progressive multifocal leukoencephalopathy in a patient with relapsing-remitting multiple sclerosisAndrew W Barritt, Esther Das, Nadine Morley, et al.
The Journal of Clinical Endocrinology and Metabolism|July 16, 2020
Development of Autoimmune Thyroid Disease in Multiple Sclerosis Patients Post-Alemtuzumab Improves Treatment ResponseAlina Sovetkina, Rans Nadir, Antonio Scalfari, et al.
Practical Neurology|June 23, 2025
Myelin oligodendrocyte glycoprotein-antibody disease (MOGAD) with leukodystrophy-like presentationViveka Biswas, Laura Martin, Emma A Lim, et al.
Immunology|October 24, 2024
Sphingosine-1-Phosphate Signalling Inhibition Suppresses Th1-Like Treg Generation by Reversing Mitochondrial UncouplingRachel Coulombeau, Claudia Selck, Nicolas Giang, et al.
Clinical Nutrition ESPEN|June 20, 2024
A systematic review and meta-analysis of Dietary Inflammatory Index and the likelihood of multiple sclerosis/ demyelinating autoimmune diseaseEsmaeil Yousefi Rad, Somayeh Saboori, Thanasis G Tektonidis, et al.
BMJ Open|April 27, 2023
Carbon dioxide flushing versus saline flushing of thoracic aortic stents (INTERCEPTevar): protocol for a multicentre pilot randomised controlled trialStephen Crockett, Lydia Hanna, Abhinav Singh, et al.
Pageof 17

Showing results (101-110 of 165) with videos related to

Sort By:
Pageof 17
Annals of Neurology|February 14, 2025
Mapping Molecular Pathways of Multiple Sclerosis: A Gene Prioritization and Network Analysis of White Matter Pathology TranscriptomicsGianmarco Abbadessa, Ai Nagano, Simon Hametner, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|August 6, 2016
A Comparison of Magnetization Transfer Methods to Assess Brain and Cervical Cord Microstructure in Multiple SclerosisAlfonso Lema, Courtney Bishop, Omar Malik, et al.
Neurology|July 6, 2012
Increased PK11195 PET binding in the cortex of patients with MS correlates with disabilityMarios Politis, Paolo Giannetti, Paul Su, et al.
Brain : a Journal of Neurology|August 16, 2011
Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosisOwain W Howell, Cheryl A Reeves, Richard Nicholas, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 1, 2022
Management approach including pembrolizumab for fingolimod-associated progressive multifocal leukoencephalopathy in a patient with relapsing-remitting multiple sclerosisAndrew W Barritt, Esther Das, Nadine Morley, et al.
The Journal of Clinical Endocrinology and Metabolism|July 16, 2020
Development of Autoimmune Thyroid Disease in Multiple Sclerosis Patients Post-Alemtuzumab Improves Treatment ResponseAlina Sovetkina, Rans Nadir, Antonio Scalfari, et al.
Practical Neurology|June 23, 2025
Myelin oligodendrocyte glycoprotein-antibody disease (MOGAD) with leukodystrophy-like presentationViveka Biswas, Laura Martin, Emma A Lim, et al.
Immunology|October 24, 2024
Sphingosine-1-Phosphate Signalling Inhibition Suppresses Th1-Like Treg Generation by Reversing Mitochondrial UncouplingRachel Coulombeau, Claudia Selck, Nicolas Giang, et al.
Clinical Nutrition ESPEN|June 20, 2024
A systematic review and meta-analysis of Dietary Inflammatory Index and the likelihood of multiple sclerosis/ demyelinating autoimmune diseaseEsmaeil Yousefi Rad, Somayeh Saboori, Thanasis G Tektonidis, et al.
BMJ Open|April 27, 2023
Carbon dioxide flushing versus saline flushing of thoracic aortic stents (INTERCEPTevar): protocol for a multicentre pilot randomised controlled trialStephen Crockett, Lydia Hanna, Abhinav Singh, et al.
Pageof 17